Concepedia
Publication | Open Access
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis
253
Citations
29
References
2021
Year
Page 1